Leading experts in spinal muscular atrophy (SMA) explore factors influencing treatment decision-making with approved SMA therapies using three patient case studies.
Watch here: https://touchneurology.com/cme/selecting-disease-modifying-treatments-in-sma/
This activity is funded by an independent medical education grant from Biogen and Novartis Gene Therapies. This activity is jointly provided by USF Health and touchIME.
Watch here: https://touchneurology.com/cme/selecting-disease-modifying-treatments-in-sma/
This activity is funded by an independent medical education grant from Biogen and Novartis Gene Therapies. This activity is jointly provided by USF Health and touchIME.
- Category
- Health
Be the first to comment